At a glance
- Originator Bristol-Myers Squibb
- Class Antifungals; Cytostatic antibiotics; Lactones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 May 1995 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 03 Nov 1994 Preclinical development for Cancer in USA (Unknown route)